5 news items
Rallybio Presents Results Of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially And Ethnically Diverse Populations
RLYB
17 Jun 24
Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates
RLYB
9 May 24
investigating the genetic markers of FNAIT risk in a racially and ethnically diverse population beyond the Caucasian population, where FNAIT risk has been
Rallybio Corporation Announces FNAIT Systematic Literature Review And Meta-Analysis Presented At The Academy Of Managed Care Pharmacy 2024 Annual Meeting
RLYB
17 Apr 24
dataset for HPA-1a alloimmunization frequency in a racially and ethnically diverse population, which is intended to support a future Phase 3
FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting
RLYB
17 Apr 24
an ongoing FNAIT natural history study that will provide a contemporary dataset for HPA-1a alloimmunization frequency in a racially and ethnically diverse
Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
RLYB
10 Apr 24
and ethnically diverse population that is intended to support a future RLYB212 registration study. Pregnant individuals who are already alloimmunized
- Prev
- 1
- Next